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Abstract
Recurrent events together with longitudinal measurements are commonly observed
in follow-up studies where the observation is terminated by censoring or a primary
failure event. In this dissertation, we developed joint modeling methods for recurrent
events, longitudinal measurements and survival data. We developed a joint model
where the dependence of longitudinal measurements, recurrent event process and
time to failure event is modeled through rescaling the time index. The general idea is
that the trajectories of all biology processes of subjects in the survivors’ population
are elongated or shortened by the rate identified from a model for the failure event.
To avoid making disputing assumptions on recurrent events or biomarkers after the
failure event (such as death), the model is constructed on the basis of survivors’ pop-
ulation. The model also possesses a specific feature that, by aligning failure events
as time origins, the backward-in-time model of recurrent events and longitudinal
measurements shares the same parameter values with the forward time model. The
proposed method can be generalized to analyze left-truncated data. We also devel-
oped methods to model the terminal behaviors of stochastic processes and estimate
the backward change point which is identified based on the failure event in backward
time index. As a particular application of our methods in the studies of biomarkers’
predictability in relation to disease, the rate of change of biomarkers or longitudinal
measurements could start to shift, accelerate or decelerate at a specific time prior
to the occurrence of a primary failure event, and our model is aimed to estimate
this special time point termed as a backward change point. Modeling the backward
change point is challenging because longitudinal measurements, recurrent events and
failure event are usually correlated, and the observed data are incomplete due to cen-
soring of follow-up. Our methods are on the basis of incomplete data and allow the
ii
join distribution of failure event, recurrent events and longitudinal measurements to
be unspecified except for a few common assumptions. The general idea is that we
model the longitudinal measurement process retrospectively starting from the failure
event and the failure time will be a condition of the model just like a covariate. The
statistical properties, simulation studies and real data examples are conducted.
Adviser: Professor Mei-Cheng Wang
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1.1 Overview of Statistical Problems
Recurrent events together with longitudinal measurements are frequently encoun-
tered in follow-up studies. In biomedical applications, two types of longitudinal mea-
surements are commonly observed: (i) repeated measurements collected at sampling
times, and (ii) marker measurements observed when recurrent events occur. In case
(i), longitudinal measurements are assumed to be a stochastic process which exists
continuously over time, such as CD4 cell counts in HIV studies or other disease-related
biomarkers, where recurrent events are sampling times. In case (ii), typical examples
are studies with repeated marker measurements observed upon the occurrence of re-
current events, where both recurrent events and marker measurements are of scientific
interest; an example is the medical charge upon the occurrence of hospitalization. For
either case, the observation of longitudinal measurements and recurrent events could
be terminated by censoring or a primary failure event such as death. Despite the
difference in the data generating mechanisms, these two kinds of data share the same
notations.
An example of type (i) longitudinal measurements can be the data from the
Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) cohort
study which aims at identifying biomarkers associated with the development of Alzheimer’s
Disease (AD) procession. The study was administrated by NIH from 1995 to 2005,
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and was re-established by a research group at Johns Hopkins School of Medicine after
being stopped for four years. Subjects enrolled in the study were cognitively normal
at baseline and data including cognitive performance testing scores were collected
annually or per half year during the study.
For the type (ii) longitudinal measurement, the data from the clinical trial con-
ducted by Terry Beirn Community Programs for Clinical Research on AIDS is a good
illustration where the longitudinal measurements were only observed with the occu-
rance of a recurrent event process. The study was federally funded and conducted
by national network of community-based research groups. The study compared two
kinds of treatments, didanosine (ddI) and zalcitabine (ddC), for HIV-infected pa-
tients who previously had failed treatment with or were intolerant to zidovudine.
(Abrams et al., 1994[1]) In the trial, 230 patients were randomly sellected to receive
ddI treatment and 237 to receive ddC. Patients were followed to death as the primary
endpoint, during which totally 463 opportunistic infections were observed (172 in the
ddI group and 191 in the ddc group). For each opportunistic infection, a severity score
was provided by doctors and HIV-infected patients to indicate the disease progression
(Neaton et al., 1994[28]).
Analyzing this type of data is challenging because of the complex association
within the data structure. Firstly, ignoring the dependence of longitudinal measure-
ments to survival data leads to biased results. As a simple explanation, the failure
times are possibly correlated to the longitudinal measurements and the survivors’
population will change with the time going. Thus, the changes of the longitudinal
measures are because of the time factor, the covariate effects and also the influence of
the survivors’ population variation. The traditional and commonly used methods for
longitudinal data analyses such as the generalize estimation equation models (Liang
and Zeger, 1986[19]) and the mixed effect models (Laird and Ware, 1982[18]) can
not be applied in this scenarios because these models were developed on the basis
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of independent failure event and constant population. Additionally, these two types
of models assume the sampling processes are independent with the longitudinal data
such that they can not be used to analyze the type (ii) longitudinal measurements
even without informative failure events.
Besides modeling the longitudinal data in forward time order, it is also of inter-
est to study the terminal behavior of stochastical processes in backward time index
in studies of disease progression. Particularly, it is often of practical meaning to
study biomarker performance prior to the occurrence of failure events by aligning
failure events as time origins and counting time backward. For example, in studies of
Alzheimer’s Disease the rate of change in biomarker measurement before diagnosis of
disease is widely recognized as an important index for predicting the disease (Hall et
al., 2000[8]; Wilson et al., 2007[43]). However, the conventional forward perspective
of stochastic processes are not designed for the terminal behavior of processes.
Additionally, when studying trajectories of biomarkers or other longitudinal mea-
surements before the failure event such as death, researchers sometimes find that the
rate of change of biomarkers start to shift, accelerate or decelerate, at some special
time point which is prior to the failure event by a gap time. We name this special
type of change point as backward change point to distinguish it from the traditional
forward change point which occurs after the origin point by a constant period of
time. Backward change point is of scientific interest for biology procession study
and disease diagnosis. In particular, for Alzheimer’s disease (AD) studies, Jack et
al. (2010)[12] hypothesized that the decline of biomarkers began to accelerate prior
to diagnosis in order such that different biomarkers characterized the disease during
different stages. Knowing the acceleration order of biomarkers decline will help to
measure disease progression precisely, and then therapeutic intervention can be given
to patients properly.
Consider the model where the failure time is T and the decline of biomarker
3
begins to accelerate at time point T − d for those subjects with failure time longer
than d, where d is a constant gap time. Ideally, if all of the subjects are followed
until diagnosis, the backward change point model can be analyzed by aligning the
biomarker measurements retrospectively with diagnosis as the time origin, and then
use techniques for forward change point models (e.g., Slate and Cronin, 1997[32];
Skates, Pauler, and Jacobs ,2001[31]) to estimate the parameter d.
However, in most follow-up studies, subjects may be censored due to design limi-
tations, early drop out or other reasons. For censored subjects, not only the time of
failure event is missing, the longitudinal measurements between censoring and failure
event are also unobserved. As a result, the new time origins of censored data cannot
be set and the observed longitudinal measurements cannot be indexed in backward
time index. Thus, the censoring problem of longitudinal and survival analysis studies
in backward time index is more complex than that of the studies in forward time
index. However, as a character of time-to-event data, disregarding the censoring
problem will lead to biased results even if the cenoring is noninformative.
In this dissertation, we have developed novel methods for joint modeling recur-
rent events, longitudinal measurements and survival data which allow the association
within the data structure. We have also conducted research to model the terminal
behavior of stochastic processes and especially estimate of backward change point.
1.2 Organization
The dissertation is organized as follows. We have conducted the literature reviews for
related statistical methods for joint modeling of recurent events, longitudinal mea-
surements and survival data, and the change point estimation for backward stochastic
processes in the Chapter 2. Chapter 3 contains our methods for joint modeling of
recurent events, longitudinal measurements and survival data, and the simulation
studies and real data illustrations are also included. In the Chapter 4, we present
4
our methods for the backward change poiont estimation, provide the asymptotical
inference results, and illustrate our methods by simulation studies and the real data




2.1 Literature Review of Joint Modeling of Recur-
rent Events, Longitudinal Measurements and
Survival Data
Recurrent events together with longitudinal measurements are commonly observed in
medical or public health follow-up studies. As mentioned in the Chapter 1, there are
two types of longitudinal measurements commonly observed: (i) repeated measure-
ments collected at sampling times (e.g. such as CD4 cell counts in HIV studies or
other disease-related biomarkers), and (ii) marker measurements observed when re-
current events occur (e.g. the medical charge upon the occurrence of hospitalization).
For either case, the observation of longitudinal measurements and recurrent events
can be terminated by censoring or a primary failure event such as death. Despite the
difference in the data generating mechanisms, these two kinds of data share the same
notations.
In the absence of informative sampling times, many authors (Wulfsohn and Tsiatis,
1997[45]; Henderson et al., 2000[9]; Xu and Zeger, 2001[47]; Song, Davidian, and
Tsiatis, 2002[33]; Vonesh, Greene, and Schluchter, 2006[40]; Song andWang, 2008[34])
used the shared frailty model to analyze longitudinal measurements and time-to-event
data, where multiple layers of models with shared underling random variables are
created for different data components. The general idea of shared frailty models is that
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different data components are assumed to be independent of each other conditioning
on the shared random variables, and hence the correlation within the data structure
is explained by the shared random variables. However, since these models assume
that the sampling times are indepdent witht the failure time and the longitudinal
measurements, none of them can be applied to longitudinal measurements of type
(ii).
Informative sampling times is another important topic in longitudinal studies.
For example, medical cost or some biomarkers would be measured at each time of
hospitalization. The process of hospitalization can be viewed as a recurrent event pro-
cess which could carry information for longitudinal variables. Thus, joint modeling
longitudinal measurements and recurrent events data will be beneficial and even nec-
essary in some situations. Lin and Ying (2001)[22] proposed semiparametric models
for longitudinal data with irregular sampling times, where the longitudinal response
variable is assumed to be independent of the recurrent event process conditioning
on covariates. Lin, Scharfstein and Rosenheck (2004)[23] relaxed the assumption of
independent-relationship between longitudinal variables and observational times to
some degree. The method of Sun et al. (2005)[35] allowed a flexible correlation be-
tween the two components of the data, where the recurrent event process is assumed
to be Poisson process. Liang, Lu and Ying (2009)[20] developed a shared random
effects model, where random effects were assumed to have a specific relationship de-
fined by a link function. In all these methods, assumptions of unrelated terminal
events are necessary.
Abundant attempts have been adopted to jointly model longitudinal measure-
ments, recurrent events, and time to failure events data. The shared frailty models
(Sun, Sun, and Liu, 2007[36]; Liu, Huang, and O’Quigley, 2008[25]; Liu and Huang,
2009[24]; Kim et al., 2012[14]; Sun et al., 2012[37]) form a popular approach as well.
However, some of these models can not be adopted in the situation of randomly sam-
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pled measurements, i.e., type (i), and many have limitations in computation complex-
ity. In addition, various approaches have been proposed for modeling recurrent events
together with informative failure event jointly (Wang, Qin, and Chiang, 2001[42];
Huang and Wang, 2004[10]; Liu, Wolfe, and Huang, 2004[26]; Ye, Kalbfleisch, and
Schaubel, 2007[48]; Zeng and Cai, 2010[50]). Most of these approaches consider the
association within the data structure by using the shared frailty method, except the
models in Sun et al. (2005)[35].
2.2 Literature Review of Backward Change Point
Estimation
In studies of disease progression, it is often of interest to study biomarker performance
prior to the occurrence of failure events by aligning failure events as time origins and
counting time backward. For example, in studies of Alzheimer’s Disease the rate of
change in biomarker measurement before diagnosis of disease is widely recognized
as an important index for predicting the disease (Hall et al., 2000[8]; Wilson et al.,
2007[43]). However, the conventional forward perspective of stochastic processes are
not designed for the terminal behavior of processes. To our knowledge, Chan and
Wang (2010)[4] was the first to study the backward stochastic processes and develop
a nonparametric estimation method where the failture events were treated as time
origins and the time was counted in backward order. Chan and Wang (2016) [3]
further developed a three layer semiparametric regression model for jointly modeling
the survival data, the backward recurrent event proess and the marker measured at
occurance of backeard recurrent events.
Additionally, when studying trajectories of biomarkers or other longitudinal mea-
surements before the failure event such as death, researchers sometimes find that the
rate of change of biomarkers start to shift, accelerate or decelerate, at some special
time point which is prior to the failure event by a gap time. We name this special
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type of change point as backward change point to distinguish it from the traditional
forward change point which occurs after the origin point by a constant period of
time. Backward change point is of scientific interest for biology procession study
and disease diagnosis. In particular, for Alzheimer’s disease (AD) studies, Jack et
al. (2010)[12] hypothesized that the decline of biomarkers began to accelerate prior
to diagnosis in order such that different biomarkers characterized the disease during
different stages. Knowing the acceleration order of biomarkers decline will help to
measure disease progression precisely, and then therapeutic intervention can be given
to patients properly.
Consider the model where the failure time is T and the decline of biomarker
begins to accelerate at time point T − d for those subjects with failure time longer
than d, where d is a constant gap time. Ideally, if all of the subjects are followed
until diagnosis, the backward change point model can be analyzed by aligning the
biomarker measurements retrospectively with diagnosis as the time origin, and then
use techniques for forward change point models (e.g., Slate and Cronin, 1997[32];
Skates, Pauler, and Jacobs ,2001[31]) to estimate the parameter d.
However, in most follow-up studies, subjects may be censored due to design limi-
tations, early drop out or other reasons. For censored subjects, not only the time of
failure event is missing, the longitudinal measurements between censoring and failure
event are also unobserved. As a result, the new time origins of censored data cannot
be set and the observed longitudinal measurements cannot be indexed in backward
time index. Thus, the censoring problem of longitudinal and survival analysis studies
in backword time index is more complex than that of the studies in forward time
index. However, as a character of time-to-event data, disregarding the censoring
problem will lead to biased results even if the cenoring is non-informative. To our
knowledge, there are few valid methods of modeling backward change point problems.
Some researchers (Hall et al., 2000[8]; Wilson et al., 2011[43]) have already found the
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scientific meaning of backward change point in applications, but did not consider the
censoring issue in their models. Additionally, longitudinal measurements and the fail-
ure event are usually correlated and the association within data structure should also
be considered. Unfortunately, the current methods of joint modeling of lingitudinal
measuremetns and time-to-event data (Wulfsohn and Tsiatis, 1997[45]; Henderson et
al., 2000[9]; Xu and Zeger, 2001[47]; Song et al., 2002[33]; Vonesh et al., 2006[40];
Song and Wang, 2008[34]) do not consider the backward change point problem.
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Chapter 3
Joint Modeling of Longitudinal,
Recurrent Events and Failure Time
Data for Survivors Population
3.1 Introduction
Recurrent events together with longitudinal measurements are frequently encoun-
tered in follow-up studies. In biomedical applications, two types of longitudinal mea-
surements are commonly observed: (i) repeated measurements collected at sampling
times, and (ii) marker measurements observed when recurrent events occur. In case
(i), longitudinal measurements are assumed to be a stochastic process which exists
continuously over time, such as CD4 cell counts in HIV studies or other disease-related
biomarkers, where recurrent events are sampling times. In case (ii), typical examples
are studies with repeated marker measurements observed upon the occurrence of re-
current events, where both recurrent events and marker measurements are of scientific
interests; an example is the medical charge upon the occurrence of hospitalization.
For either case, the observation of longitudinal measurements and recurrent events
could be terminated by censoring or a primary failure event such as death. Despite
the difference in the data generating mechanisms, these two kinds of data share the
same notations. This chapter presents a semiparametric joint model framework for
both types of longitudinal measurements, (i) and (ii), with covariates information.
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In the absence of informative sampling times, many authors (Wulfsohn and Tsi-
atis, 1997[45]; Henderson et al., 2000[9]; Xu and Zeger, 2001[47]; Song, Davidian,
and Tsiatis, 2002[33]; Vonesh, Greene, and Schluchter, 2006[40]; Song and Wang,
2008[34]) used the shared frailty model to analyze longitudinal measurements and
time-to-event data, where multiple layers of models with shared underlining random
variables are created for different data components. The general idea of shared frailty
models is that different data components are assumed to be independent of each other
conditioning on the shared random variables, and hence the correlation within the
data structure is explained by the shared random variables. However, since these
models assume that the sampling times are indepdent, none of them can be applied
to longitudinal measurements of type (ii). Abundant attempts have been adopted
to jointly model longitudinal measurements, recurrent events, and time to failure
events data. The shared frailty models (Sun, Sun, and Liu, 2007[36]; Liu, Huang,
and O’Quigley, 2008[25]; Liu and Huang, 2009[24]; Kim et al., 2012[14]; Sun et al.,
2012[37]) form a popular approach as well. However, some of these models may not
be applicable to randomly sampled measurements, i.e., type (i) data, due to spe-
cific model restrictions for recurrent event processes. In addition, various approaches
have been proposed for jointly modeling longitudinal measurements and recurrent
events with uncorrelated failure event (Lin and Ying, 2001[22]; Lin, Scharfstein, and
Rosenheck, 2004[23]; Sun et al., 2005[35]; Liang, Lu, and Ying, 2009[20]), and mod-
eling recurrent events together with informative failure event jointly (Wang, Qin,
and Chiang, 2001[42]; Huang and Wang, 2004[10]; Liu, Wolfe, and Huang, 2004[26];
Ye, Kalbfleisch, and Schaubel, 2007[48]; Zeng and Cai, 2010[50]). Most of these ap-
proaches consider the data correlation by using the shared frailty method, except the
models in Lin and Ying (2001)[22], Lin et al. (2004)[23] and Sun et al. (2005)[35].
In this chapter, we consider a joint model of longitudinal measurements, recurrent
events and time to failure events, which is a useful alternative to the shared frailty
12
method and is applicable to both two types of longitudinal measurements (i) and (ii).
The time rescaling technique was previously adopted by Ghosh and Lin (2003)[7] and
Huang and Wang (2003)[11] for modeling recurrent events together with informative
failure events. Luo, Wang, and Huang (2008)[46] also provides a detailed comparison
of different models. Our model has the features that the trajectories of all biology
processes are targeted on subjects in the survivors’ population, where a subject’s fail-
ure time is elongated or shortened by the rate identified from a failure time model for
the failure event. Hence, our method can be developed without disputing assumption
on the recurrent events or biomarkers after death. In contrast with the shared frailty
method, our model does not involve latent variable and the proposed methodological
procedure is computationally simpler.
Besides the forward time model, by aligning failure events as time origins, we
will also study statistical model and inference of recurrent events and longitudinal
measurements backward in time. For many diseases, including Alzheimer’s Disease,
the changes in biomarker performance before diagnosis of disease is widely recognized
as an important index for predicting the disease (Hall et al., 2000[8]; Wilson et al.,
2007[43]). The conventional stochastic process models are always forward in time and
not designed to study terminal behavior of processes. However, backward process
models are more relevant for studying these terminal behavior (Chan and Wang,
2010[4]; Chan and Wang, 2016). In this chapter, we will show that our model, though
developed in forward time scale, has the consistent interpretation in the backward
models under proper assumptions.
In Section 3.4, the method is generalized to the case where left truncation in fail-
ure time data is present. It handles the sampling designs when the study recruits
only subjects who have experienced the initiating event but have not experienced the
failure event. Under left truncation, it is well known that the time from initiating
event to failure event tends to be longer than the failure time from the target pop-
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ulation. We will use a data example from the Alzheimer’s Disease to illustrate the
proposed method.
The chapter is organized as follows. Section 3.2.1 introduces the joint model and
discusses the interpretation of the joint model. An alternative model is presented in
Section 3.2.2 and we show that the model has consistent interpretation in backward
time perspective. Section 3.3 describes the estimation procedures and develops statis-
tical properties of the proposed semiparametric estimators. The generalization to left
truncation is discussed in Section 3.4. In Section 3.5, we evaluate the performance of
the estimating methods by simulation studies. Real data from an Alzheimer’s Disease
study and an AIDS study are used as illustrating examples for data analysis in Section
3.6. Additional discussions are in included Section 3.7 to conclude the chapter.
3.2 Survivors’ Model
3.2.1 A Time-Adjusted Forward Model
Let T be the time from an initial event to the failure event which is in continuous time
scale, Z a p × 1 vector of covariates, and R∗(t) the counting process of the number
of sampling times at or before time t. The longitudinal process Y (t) is measured
repeatedly at time t where dR∗(t) = 1. Suppose that the study is conducted in
the time interval [0, τ ] and, potentially, the data information of {T,R∗(t), Y (t)} is
observed for 0 ≤ t ≤ τ . In reality, due to limitation in experimental design or
other reasons, the data are subject to right censoring and only partially observed.
Let CR be the censoring time for observing the sampling times and the longitudinal
measurements {R∗(·), Y (·)}. Let CT be the censoring time for the failure event.
When framing the proposed model, we shall consider only the recurrent events and
the longitudinal measurements occurring before the failure event, i.e. t ≤ T .
Consider the following assumption:
(A1) {T,R∗(·), Y (·)} is independent of (CT , CR) conditioning on Z.
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Under Assumptions (A1), we consider a time-adjusted forward model to charac-




















































=E {Y0 (t) |T0≥ t, R∗0 (dt)=1}+ β′YZ,
(3.1)
where βT , βR and βY is a p × 1 vector of parameters, and T0, R∗0(·) and Y0(·) are
respectively the baseline failure time, the baseline recurrent event process and the
baseline longitudinal process. Here the baseline variables for subjects with Z = 0.
The three components {T0, R∗0(·), Y0(·)} are distribution-free and possibly correlated.
Of note, the notations {T0, R∗0(·), Y0(·)} represent individual-level variables or pro-
cesses, and {T0i, R∗0i(·), Y0i(·)} will be used in later sections as variables or processes







is used to indicate the























We use Figure 3.1 to introduce the main idea of time rescaling. Suppose there are
longitudinal measurements for treatment and controll groups until their failure events.
We assume that their longitudinal measurements will have the same type of trajectory
since we suppose the disease development process is similar for the whole population.
Assume the speed of disease development process of the treatment group is slow, and
therefore the survival time is longer and the data trajectory is elongated compared
to that of the control group. If we adjust the data trajectory of the treatment group
and let it has the same disease development speed with that of control group, the
two biomarker trajectories should be the same except for an additional shift. The
time rescaling rate is defined by the ratio of survival times. In summary, our method
supposes that one part of the covariate effect is time rescaling effect, and another
part is represented by the additive shift term.
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(3.1) to capture the covariate effects on the survivors’ population and avoids the ar-
guable issue of longitudinal variables or recurrent events after the failure time. Addi-
tionally, the survivors’ population changes when t varies, and this special characteris-
tic is indicated by the condition (T ≥ t). The conditioning eventR∗ (exp(β′TZ)dt) = 1
in the third layer of Model (3.1) is a natural condition for type (ii) data, since the
marker measurement Y (t exp(β′TZ)) exists and is observed given the occurrence of a
recurrent event. For type (i) longitudinal measurement, Model (3.1) models the mean
trajectory and covariate effect only for the observed Y (.), but the result generalizes
to the underlying Y (.) if Y (.) and R(.) are independent given Z. Similar conditions
are employed for type (i) data in Lin and Ying (2001)[22].
As mentioned in Section 1, Model (3.1) is applicable to the two types of longitu-
dinal measurements (i) and (ii), where the rate of sampling process in the rescaled
time index is changed by a multiplier exp(β′TZ) compared to baseline. For the spe-
cial case when the rate of sampling points is pre-planned and constant overtime, the
rate of R∗(t) is not influenced by covariates and we have βR = βT . In this case, the
non-zero βR is the rescaling effect rather than the covariate effect. Note that the
case βR = 0 implies that the recurrent event process is affected by the covariates
only through rescaling the time to failure event, where the recurrent event process
is stretched or compressed. Thus, a positive or negative βR reflects the additional
inflation or deflation of the frequency of R∗(·) explained by the covariates.
3.2.2 An Alternative Model and Its Backward Property
By rescaling time index, we construct an alternative model, termed as Model (3.2).
This model is slightly stronger than Model (3.1), and possesses an attractive feature
of having consistent interpretation in both the forward and backward models as will
















































= E {Y0(t) |T0, R∗0 (dt)=1}+ β′YZ, t∈[0, T0]
(3.2)
Model (3.2) extends the joint model of failure time and recurrence events studied by
Huang and Wang (2003) to a joint model with the additional longitudinal measure-
ment Y (·). Note that by conditioning on T , the baseline failure time T0 plays a role
similar to a subjective-specific random effect or frailty, and the model identifies the



















ZE {R∗0 (dt) | T0 ≥ t} .










































































1[T0≥t] {E (Y0 (t) | T0, R∗0 (dt) = 1) + β′YZ} | R∗0 (dt) = 1,Z
]
{P (T0 ≥ t | R∗0 (dt) = 1,Z)}−1
=E {Y0(t) | T0 ≥ t, R∗0 (dt) = 1}+ β′YZ.
Thus, the regression model of Y (·) in Model (3.1) would be validated by Model (3.2),
and a similar argument extends to the model for R∗(·) to conclude that the validity
of Model (3.2) implies Model (3.1). Essentially, Model (3.1) can be thought of as a
marginal model of Model (3.2), since T is used as a part of conditional statistics in
the latter but not in the former.
Interestingly, as a special property, Model (3.2) implies the validity of a backward
time model with the same parameter value. The backward time model can be used
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to study the terminal behaviors of the biological processes where the failure event
is aligned as the time origin and time is counted backward. Backward time models
offer a natural and direct way to study terminal behavior of recurrent markers. Using
the human immunodeficiency virus (HIV) infection as an illustrating example, it is
scientifically and clinically interesting to understand the pattern of the frequency
and severity of opportunistic infections before death. Evidence suggests that HIV-
infected patients experienced higher frequency of AIDS-defining events before death,
where the frequencies could vary with gender, risk behaviors or geographic location
(Chan et al., 1995[2]). Similar terminal behaviors are studied for Alzheimer’s Disease
(Wilson et al., 2007[43]), renal disease (Usvyat et al., 2013[38]) and functional decline
in the general population (Lunney et al., 2003[27]). To set notation, let the backward
time index be denoted by tB which stands for the time counted retrospectively from
the failure event. Define the backward process of the longitudinal measurement as
Y B(tB;T ) = Y (T − tB) and the backward recurrent event process as RB(tB;T ) =
R∗(T )−R∗((T − tB)−), where 0 ≤ tB ≤ T .
Under Assumptions (A1), by aligning failure events as time origins and counting
time backward, it can be proved that Model (3.2) holds if and only if the following











































































Model (3.3) assumes that the trajectories of a subject’s backward recurrent event and
longitudinal measurement processes are elongated or shortened by the scale identified
from the accelerated failure time model, where covariates influence the rate ofRB(·) by
a multiplicative term exp(β′RZ) and influence the measurement Y
B(·) by an additive
term β′YZ, respectively. Model (3.3) is consistent with Model (3.2) in the sense that
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they are equivalent to each other and share the same parameter values. This property
implies that estimation of Model (3.3) can be derived through estimation of Model
(3.2), as what we will establish in the next section. The proof for equivalence between
Models (3.2) and (3.3) is provided in Section 3.8.1.
3.3 Estimation
In this section we introduce and discuss the estimation procedures of Models (3.1)
and (3.2). Define XT = T ∧ CT , XR = T ∧ CR, and R(t) = R∗(t ∧ XR), where
a ∧ b = min(a, b). Let ∆ = 1[T≤CT ] be the censoring indicator of the failure event.
Assume the observations {XT i,∆i, XRi, Ri(·), Yi(·),Zi}, i = 1, . . . , n, are independent
and identically distributed (i.i.d.). For most applications, the censoring time for
recurrent events and longitudinal measurements is either the same as or less than the
censoring time for the failure event. We therefore assume P (CR ≤ CT ) = 1.
We construct three-layer estimation functions for βT , βR, βY , separately but in a
certain ordering, for Model (3.1). As the first step, the weighted log-rank estimating
equations (Tsiatis, 1990) is popular among other approaches (Buckley and James,
1979; Ritov, 1990) for estimating βT in the AFT model. We define the adjusted






] and the adjusted






















dNT i(t;βT ), (3.4)
where WT (t;βT ) is a non-negative weight function. A zero-crossing of UT (βT ) =
0 exists, termed as β̂T , as the estimator of βT which is strongly consistent and
asymptotically normal under regular conditions (Ying, 1993[49]).
In the next step we use the approach of Huang and Wang (2003) to construct an
estimator for βR. For given βT , define the adjusted risk-set indicator of recurrent
20






] and the adjusted counting process of
















Zi − Z̃(t;βT ,βR)
}
dNRi(t;βT ), (3.5)













and WR(t;βT ,βR) is a non-negative
weight function. IfWR(t;βT ,βR) does not depend on βR, UR(βR;βT ) is a monotone
function of βR and its zero-crossing is a consistent estimator of βR (Huang and Wang,
2003). Replacing βT by β̂T , we solve the equation UR(βR; β̂T ) = 0 instead and
denote the zero-crossing solution as β̂R.
In the third step of estimation, we estimate the parameters βY via an estima-
tion equation of (βY , β̂T , β̂R). The rate function of recurrent events process in sur-
vivors’ population at baseline is E {dR∗0(t) | T0 ≥ t} = P (T0 ≥ t)−1 dE {R∗0(t)} , and
the baseline cumulative recurrence rate function of survivors’ population is ΛR0(t) =
∫ t
0
P (T0 ≥ u)−1 dE {R∗0(u)} . To simplify notation, we define
α0(t) = E {Y0(t) | T0 ≥ t, R∗0 (dt) = 1}











P {T0 ≥ u}
dE {R∗0(u)} .
(3.6)





















Therefore, a mean-zero stochastic process for the ith subject can be expressed as

































WY (t;βT ,βR,βY )Zi dMY i(t;βT ,βR,βY ,A0) = 0. (3.9)











































Replacing A0(t) by Â0(t) in (3.9), we create an estimating function of βY with given
{βT ,βR}:






WY (t;βT ,βR,βY )
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Simple algebraic calculation yields







WY (t;βT ,βR,βY )
(
Zi − Z̃(t;βT ,βR)
)
dMY i(t;βT ,βR,βY ,A0).
So, by similar arguments of Lin et al. (2000), n−1/2UY (βY ;βT ,βR) will converge
weakly to a zero mean Gaussian process with continuous sample paths. A zero-root
of UY (βY ;βT ,βR) = 0 will be a consistent estimator of βY .
Replacing βT and βR by β̂T and β̂R respectively, we estimate βY by the zero-root
solution of the equationUY (βY ; β̂T , β̂R) = 0. If the weight functionWY (t;βT ,βR,βY )






































































which substantially relaxes the burden of computation.
Under Model (3.2), the estimation procedures are essentially the same as those
under Model (3.1) because Model (3.1) is induced from Model (3.2): By re-defining
dA0(t) = E [Y0(t)R
∗
0(dt) | T0 ≥ t, R∗0 (dt) = 1]
the regression parameters can be estimated by solving estimating equations (3.4),
(3.5) and (3.11) (see Section 3.8.2). The estimation of the backward model, (3.3),
can also be achieved via Model (3.1).
We develop asymptotic properties of the regression estimators with constant weight













′, and the trivariate estimating function
U (β) = (UT (βT )
′,UR(βR;βT )
′,UY (βY ;βT ,βR)
′)′.
Similar to Ying (1993)[49] and Lin et al. (2000), we introduce the following conditions:
(C1) β is restricted in a compact set.
(C2) {Zi, Ti, R∗i (·), Yi(·)}, i = 1, . . . , n are i.i.d. with uniform bound.
(C3) The densities of T and dR∗(t) and their first order differential functions
are bounded.
(C4) The censoring time CT and CR have uniformly bounded densities, termed
as gT and gR respectively, e.g. there isBc such that |gT (t)| < Bc and |gR(t)| < Bc
for all t.
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(C5) E|min{lnT − β′TZ, CT , CR}|φ <∞ for some φ > 0.
Theorem 3.3.1 Under conditions (C1-5), n−1/2U (β) converges weakly to a multi-
variate normal random variable with mean zero and variance denoted as Σ, and U (β)
is asymptotically linear in the sense that there exists a matrix An such that for every
sequence dn > 0 with dn → 0 in probability, we have
sup
‖b−β‖≤dn
‖ U (b)−U (β)−Ann(b− β) ‖ /(
√
n+ n ‖ b− β ‖) = op(1).
If the eigenvalues of An are all bounded away from zero for all large enough n and
An → A where A is nonsingular, there exists a closed neighborhood N containing β
as its interior point such that β̂ is strongly consistent and n1/2(β̂ − β) converges to
N (0, A−1Σ(A−1)′) weakly in N .
The proof of Theorem 3.3.1 is presented in the Section 3.8.3. Of note, the matrix
A involves the true distributions of recurrent events, longitudinal measurements and
censoring with covariates, and is hard to estimate in practice. For data applications
we will use the Bootstrap approaches to estimate the confidence intervals.
3.4 Extension to Left Truncation
In biomedical studies, left-truncated sampling is commonly adopted, where only those
subjects who have experienced the initiating event but have not experienced the fail-
ure event are recruited and followed until the occurrence of failure event or censoring;
see Wang, Brookmeyer, and Jewell (1993)[41], among others. The failure time of
interest is still the time from initiating event to failure event in the target population,
and this type of sampling results in left-truncated and right-censored failure time data
along with accompanied recurrent events and longitudinal measurements. For exam-
ple, in Alzheimer’s Disease studies, the failure time T is age at onset of symptoms of
Mild Cognitive Impairment (MCI), and the study recruited and followed only those
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subjects who were disease-free at baseline. The observed data sample then forms an
example of left-truncated and right-censored data.
Our Model (3.1) and the subsequently developed inferential approach can be gen-
eralized to left-truncated and right-censored data under the conditional independent
left truncation and right-censoring assumption, i.e. {T,R∗(·), Y (·)} is independent
of (CT , CR, L) where L is the left trucation time, given covariates Z. Suppose
the observations {Li, XT i,∆i, XRi, Ri(·), Yi(·),Zi}, i = 1, . . . , n, are i.i.d. subject to
Li < XT i∧XRi. To estimate Model (3.1) under the left-truncated and right-censored
sampling, we re-construct the risk set indicators and the counting processes (Andersen




















], and NLRi(t;βT ) =
R∗i (t exp(β
′
TZi) ∧ XRi)1[Li≤t exp(β′TZ i)
]. Estimation procedures similar to those in
Section 3 can be achieved using the following three-layer estimation functions:



















































− β′YZi} dNLRi(t;βT ),
where Z̃
L



















We conducted simulation studies to assess the finite sample performance of the pro-
posed methods. For each simulation study, we repeatedly generated 1, 000 simulated
data sets. In each data set, the ith individual’s sample is generated by the following
procedure:
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• Generate the covariate vector Zi.
• Generate the potential baseline failure time T0i independently with Zi. Since
T0i > 0, we generate a random variable Vi independent with Zi and define
T0i = exp(Vi). Thus, conditioning on T0i is equivalent to conditioning on Vi.
• Define the failure time as Ti = exp(β
′
TZi)T0i.
• Conditioning on {Vi,Zi}, generate the sampling time process R∗i (·) on [0, τ ] as
a nonhomogeneous Poisson process with intensity
λi(t;Zi, Vi) = exp(β
′
RZi) exp(−β′TZi)h(t exp(−β′TZi), Vi),
where h(·, ·) is a prespecified positive function. Of note, this intensity function








• Given Vi and Zi, at each sampling time t, generate the longitudinal variable by
Yi(t) = β
′
YZi + a(t exp(−β′TZi)) + εi(t), where εi(t) has normal distribution
N(µ(Vi), σ
2(Vi)). Here a(·), µ(·) and σ2(·) are prespecified functions.
• Generate censoring times {CT i, CRi} which depend on the covariate Zi but do
not depend on Vi. Here, we set CT i = CRi = Ci.
In Table 3.1 all the specific distributions used to generate the simulated data are
listed. The simulation procedure follows Model (3.2) exactly and is determined by the
prespecified components: τ , distributions of {Zi, T0i, Ci}, functions {h(·, ·), µ(·), σ2(·), a(·)},
and parameters {βT ,βR,βY }. The simulation procedure is also valid for Model
(3.1). We examined several settings, with continuous and discrete covariates, dif-
ferent covariate dimensions, various associations within {T,R∗(·), Y (·)}, and dif-
ferent sample sizes. For the estimating procedure, we set weighting functions as
WT (t;βT ) = n
−1 ∑n
i=1 ξTi(t;βT ) which leads to the Gehan estimating function, and
WR(·) = WY (·) = 1.
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The simulation results are summarized in Table 3.1. Scenario 0 simulated the
special case of type (i) longitudinal measurements with the constant samping rate
overtime. Note that R∗(·) was not influenced by Z in this case and we let βR equal
βT for the reason mentioned in the Section 3.2.1. The samping process considered
in Scenario 1 followed a stationary Poisson process and was independent after condi-
tioning on Z. In Scenarios 2-3, T were correlated with both R∗(·) and Y (·). Scenario
1 and 2 involved a continuous and a discrete one-dimensional covariate separately.
Scenario 3 mimicked a two-arm clinical trial with one covariate from Bernoulli distri-
bution and another covariate from uniform distribution. We used the empirical bias,
standard errors and 95% bootstrap confidence intervals for (βT ,βR,βY ) to evaluate
the performance of the estimation method. The bootstrap procedure was based on
1, 000 replications, where subjuects were sampled with replacement and parameters
{βT ,βR,βY } were estimated for each replication. As shown in Table 3.1, the esti-
mating method performed well in all the situations considered here. In particular, the
95% bootstrap confidence interval of βY has empirical coverage probabilities ranging
from 0.925 to 0.954 which accords with the asymptotic normality property.
Our method can handle the joint modeling of recurrent events and longitudinal
measurements data in the absence of informative terminal event by letting βT = 0.
We also conducted simulations on sensitivity analysis under the Scenario 2 to illustrate
what would happen if the dependence with failure times was ignored. Particularly,
we ignored the first layer AFT model and set βT = 0 in the second and third layers of
the Model (3.2). The simulation results for βR and βY were summarized in Table 3.2,
which shows that ignoring dependence of data with failture times can lead significantly
biased results if the dependence exists.
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Table 3.1: Summary Statistics of the Simulation Studies
βT βR βY
n Bias SE CP Bias SE CP Bias SE CP
Scenario 0: Z ∼ B(1, 1
2
), V ∼ N(0, 1
4
), τ = 7, h(t, V ) = 0.015, a(t) = t2 + t, µ(V ) = V ,
σ2(V ) = V 2, logC ∼ N [Z, (|Z|+ 1)2]
βT = −0.5 βR = −0.50 βY = −1
n = 100 −0.004 0.121 0.944 −0.008 0.252 0.939 0.013 0.442 0.940
n = 200 −0.000 0.083 0.962 −0.010 0.171 0.944 0.027 0.317 0.952
βT = 1 βR = 1 βY = 2
n = 100 0.006 0.130 0.949 0.026 0.211 0.942 −0.001 0.367 0.941
n = 200 0.003 0.091 0.942 0.009 0.146 0.937 0.004 0.262 0.944
Scenario 1: Z ∼ U [0, 1], V ∼ Exp(1), τ = 7, h(t, V ) = 0.01, a(t) = sin(t), µ(V ) = V ,
σ2(V ) = V 2, C ∼ U [0, 12] if Z < 0.5 and C ∼ U [0, 15] if Z ≥ 0.5
βT = 1 βR = 0 βY = 0
n = 100 0.002 0.220 0.944 0.028 0.351 0.937 0.028 0.680 0.937
n = 200 0.002 0.144 0.962 0.010 0.237 0.946 0.008 0.472 0.941
βT = 0.5 βR = −0.5 βY = 3
n = 100 0.003 0.226 0.941 0.005 0.352 0.941 −0.009 0.715 0.925
n = 200 −0.002 0.147 0.949 −0.005 0.253 0.943 −0.002 0.502 0.935
Scenario 2: Z ∼ B(1, 1
2
), V ∼ N(0, 1
4
), τ = 7, h(t, V ) =
√
3t|V |/50, a(t) = t2, µ(V ) =
√
|V |,
σ2(V ) = |V | ∧ 1, C ∼ U [0, 12] if Z = 1 and C ∼ U [0, 15] if Z = 0
βT = 1 βR = −1 βY = 2
n = 100 0.002 0.111 0.937 −0.000 0.335 0.941 −0.021 0.470 0.938
n = 200 −0.006 0.077 0.943 −0.008 0.224 0.951 −0.028 0.334 0.952
βT = −0.5 βR = 0 βY = −1
n = 100 −0.003 0.107 0.944 −0.018 0.271 0.957 0.005 0.464 0.942
n = 200 0.003 0.072 0.959 −0.007 0.189 0.955 0.043 0.350 0.942
Scenario 3: Z1 ∼ B(1, 12 ), Z2 ∼ U [0, 1], V ∼ N(0, 14 ), τ = 7, h(t, V ) =
|tV |
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, a(t) = t,
µ(V ) = V , σ2(V ) = V 2, C ∼ U [0, 12] if Z1 = 0 and C ∼ U [0, 15] if Z1 = 1
βT = (1, 0.5)














































































Note: Bias, the empirical bias; SE, the empirical standard error; CP , the empirical coverage
probability of 95% bootstrap confidence interval; B(1, 1
2
), the Bernoulli distribution; N(µ, σ2), the
normal distribution; U [l1, l2], the Uniform distribution; Exp(λ), the Exponential distribution.
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Table 3.2: Summary Statistics of the Sensitivity Study under Scenario 2
βR βY
n Bias SE CP Bias SE CP
{βT , βR, βY } = {1,−1, 2}
n = 100 −1.823 0.318 0.001 −2.788 1.178 0.021
n = 200 −1.821 0.227 0.000 −3.169 1.109 0.000
{βT , βR, βY } = {−0.5, 0,−1}
n = 100 0.904 0.192 0.016 1.482 0.582 0.023
n = 200 0.902 0.135 0.000 1.609 0.479 0.000
Note: Bias, the empirical bias; SE, the empirical standard error; CP , the empirical coverage
probability of 95% bootstrap confidence interval.
3.6 Data Analysis
3.6.1 BIOCARD Data Analysis
As an example of type (i) longitudinal measurements, we consider the application of
our models on the data from the Biomarkers of Cognitive Decline Among Normal
Individuals (BIOCARD) cohort study which aims at identifying biomarkers associ-
ated with the development of Alzheimer’s Disease (AD) procession. The study was
administrated by NIH from 1995 to 2005, and was re-established by a research group
at Johns Hopkins School of Medicine after being stopped for four years. Subjects en-
rolled in the study were cognitively normal at baseline and data including cognitive
performance testing scores were collected annually or per half year during the study.
The ε4 allele of the apolipoprotein E (ApoE) gene is the main genetic risk factor
associated with AD dementia (Farrer et al., 1997[6]). Our main object here is to
estimate the effect of the ApoE4 gene on the time onset of clinical symptoms and
the cognitive performance testing score Logical Memory IIA - delayed. Here we only
considered the data collected at the even follow-up years in 1995-2005. Totally, we had
236 subjects, consisting of 71 ApoE4 carriers and 165 ApoE4 non-carriers, and the
overall censoring rate is 73.7%. Figure 3.6.1 shows the BIOCARD data of uncensored
subjects in forward and backward time scales. We first analyzed the data as the right-
censored case where the individual enrollment time was the time origin. Let Ti be the
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time from entry to the onset of symptoms for mild cognitive impairment (MCI), Ri(·)
be the sampling process since entry and Yi(·) be the cognitive score, i = 1, . . . , 236.
This longitudinal measurement is selected because it is found to be a highly predictive
marker for onset of symptoms. Since subjects were enrolled at different baseline ages,
the centered baseline age of each individual was considered as covariate. By defining
the failure time Ti as the age at onset of symptoms, the second set of data analysis is
conducted by treating the observed data as being left-truncated and right-censored,
where the truncation time Li is an individual’s age at the time when she or he entered
the study. In this analysis ApoE4 status was the only covariate.
The analysis results are reported in Table 3.3. For the right-censored data setting,
the ApoE4 gene type has a time rescaling effect identified by the AFT model. The
positive ApoE4 gene type accelerates the progress of disease and, as a result, the
time to onset of symptoms is shortened by the rate exp(−0.209) for subjects with the
same baseline age. Furthermore, the score in the ApoE4 carriers population at time
t exp(−0.209) averagely equals to that in the ApoE4 non-carriers population at time
t with an additional increase by a coefficient with value 0.560. Of note, βY represents
the addition shift effect after being adjusted by the time-rescaling effect, and therefore
these two effects should be considered together to understand the covariate effect.
Neither the time rescaling effect nor the additional shift effect of ApoE4 gene type
showed significant effects according to the 95% bootstrap confidence intervals with
1, 000 bootstrap repetitions. In contrast, the increase of baseline age significantly
accelerates the disease process and reduces the score as shown in Table 3.3.
For the left-truncated and right-censored data setting, using a subject’s age at
onset of symptoms as the failure time, the positive ApoE4 gene type accelerates the
progress to disease and shortens the age of onset of symptoms by rate exp(−0.044).
Furthermore, the ApoE4 gene type influenced the rescaled recurrent event proess with
an additional multiplier term exp(−0.035). As to the effect of ApoE4 on the score,
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Figure 3.2: Illustration of BIOCARD Data for Uncensored Subjects in Forward and
Backward Time Indices
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ApoE4+ −0.209 (−0.558, 0.167)
Baseline Age −0.040 (−0.065,−0.022)
βR
ApoE4+ −0.121 (−0.543, 0.321)
Baseline Age −0.029 (−0.065,−0.005)
βY
ApoE4+ 0.560 (−2.001, 3.166)
Baseline Age 0.161 (−0.028, 0.547)
Case 2 Left Truncation and Right-Censoring
βT ApoE4+ −0.044 (−0.125, 0.029)
βR ApoE4+ −0.035 (−0.250, 0.236)
βY ApoE4+ 0.831 (−2.998, 2.515)
Note: 95% CI, bootstrap percentile 95% confidence interval.
it provides an additional shift effect by 0.831, but nonsignificantly.
3.6.2 CPCRA Data Analysis
To illustrate the application of the proposed method on type (ii) longitudinal mea-
surement, we analyzed data from a clinical trial conducted by Terry Beirn Community
Programs for Clinical Research on AIDS. The study compared two different treat-
ments, didanosine (ddI) and zalcitabine (ddC), for HIV-infected patients who had
previously failed treatment with or were intolerant to zidovudine (Abrams et al.,
1994[1]). In the trial, 230 patients were randomly sellected to receive ddI treatment
and 237 to receive ddC, the event of death is the primary endpoint, and patients were
followed until death or censoring. During the course of the trial 363 opportunistic
infections were observed, of which 172 were in the ddI group and 191 in the ddc
group. For each opportunistic infection, a severity score was provided by physicians
as an indicator for the disease progression (Neaton et al., 1994[28]). The analysis in
Abrams et al. (1994)[1] suggested that ddC may have provided a survival advantage
over ddI.
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Table 3.4: Summary of CPCRA Data Analysis
Coefficient 95% CI
βT 0.179 (0.012, 0.328)
γ 0.156 (−0.025, 0.407)
βY 0.268 (−0.733, 0.831)
Note: 95% CI, bootstrap percentile 95% confidence interval.
We investigated the effect of treatment where the indicator, Z, was the only covari-
ate in the model (coded as 0 for ddI and 1 for ddC). Let T , R∗(·) and Y (·) respectively
be the time to death, the opportunistic infection process and the severity score. The
analysis results are summarized in Table 3.4, which shows that the treatment ddC
had a significant time rescaling effect and elongated the survival time by the rate
exp(0.179). The infection rate of the ddC treatment group at time t exp(0.179) is
equal to that of the ddI treatment group at time t with an additional multiplier
exp(0.156), which is not significant. Moreover, the mean severity score of the ddC
treatment group at time t exp(0.179) is equal to that of the ddI treatment group at
time t with an additional increase 0.268 which is also not significant.
3.7 Discussion
In this chapter we developed a joint model for longitudinal measurements, recurrent
events, and failure events data where all of the three components of data are treated
as outcomes. Without requiring restrict assumptions on recurrent event processes, the
proposed model is applicable to both types of longitudinal measurements, (i) and (ii).
On the basis of the survivors’ population, the model avoids the disputing assumption
on the existence of recurrent events or longitudinal measurements after the failure
event. As the model does not involve latent variables, computationally it is simpler
and easier to adopt when comparing to the shared frailty model. Moreover, the
proposed model and estimation inference can be generalized to analyze left-truncated
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and right-censored data.
The proposed model involves semiparametric structure in each of the three sub-
models, for failure time, recurrent events and longitudinal measurements, and the
baseline functions in the model are unspecified. Since the main interest of this chapter
is to model and estimate covariates effects, we will only briefly describe the approaches
for estimating the baseline functions in Section 3.8.4.
Our model possesses a specific feature that the forward time model is equivalent
to the backward-in-time model for recurrent events and longitudinal measurements,
where the two models share the same regression parameter values. Therefore, our
model can be used to study the terminal behavior of biological processes, such as
the performance of a biomarker measurement before the diagnosis of disease or the
medicine cost distributions before death. Of note, studying the terminal behavior of
a longitudinal measurement process is challenging as the censoring cannot be handled
using the standard approach (Chan and Wang, 2016). The proposed model possesses
equivalence between forward and backward time scales, which is an attractive fea-
ture when modeling stochastic processes (such as recurrent events, longitudinal or
functional measurements) in the presence of a terminal event. It has the obvious
advantage that one can build a forward time model which is also valid in backward
time scale.
Our model also has some limitations. Firstly, our model does not consider the
case of time-dependent covariates. Secondly, our model depends on the time rescaling
assumption and especially it assumes that the time rescaling rate is uniform for the
longitudinal, recurrent event and failure time data. Thirdly, our model needs the
independent censoring assumption which is usually not satisfied in follow-up studies
and competing risk occurs. For example, subjects are more likely to drop out of
studies as their cognition falls sufficiently low. It is not porper to use our model if
these assumptions are violated, but unfortunately we have not developed the model
34
diagnosis or assumption testing methods. Efforts should be made to solve these
problems in the future.
3.8 Proofs
3.8.1 Proof of Equivalence of Model (3.2) and (3.3)






































































A similar argument extends to Y B(·) with the same result.
By the symmetric argument, we can prove that Model (3.2) can be induced from
Model (3) as well.
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3.8.2 Proof of Equation (3.7)
We firstly prove Equation (3.7) under Model (1). If ξRi(t;βT ) = 0, the equation (3.7)
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P {T0i ≥ t}
=dA0(t).
Thus, we have proved the desired results which implies thatMY i(t;A0,βY ,βT ,βR)
is a mean-zero stochastic process.
The Equation (3.7) also holds under Model (3.2) which is conditioning on T . We
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let dA0(t) = E [Y0(t)R
∗




































































































































1[T0i≥t]E {Y0i (t) | T0i, R∗0i (dt) = 1}E {R∗0i (dt) | T0i}
]
{P (T0i ≥ t)}−1
=E [Y0i(t)R
∗
0i(dt) | T0i ≥ t]
=dA0(t).
3.8.3 Proof of Theorem 3.1
First we mainly prove that n−1/2UY (βY ;βT ,βR) converges weakly to a tight zero
mean Gaussian variable. Simple algebraic manipulation yields that



















MY i(t;βT ,βR,βY ,A0).
Since both
∑n
i=1MY i(t;βT ,βR,βY ,A0) and
∑n
i=1 ZiMY i(t;βT ,βR,βY ,A0) are sums
of n i.i.d. zero-mean terms, n−1/2
∑n
i=1MY i(t;βT ,βR,βY ,A0) and
n−1/2
∑n
i=1 ZiMY i(t;βT ,βR,βY ,A0) converge weakly to tight zero mean Gaussian
processes with continuous sample paths by conditions (C1-2). Since Zi is assumed
to be bounded in condition (C2), one can prove that Z̃(t;βT ,βR) converges in prob-
ability to a deterministic function, z̃(t;βT ,βR) say, uniformly in t. By repeatedly
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using Lemma 1 in Lin et al. (2000)[21], one can prove that n−1/2UY (βY ;βT ,βR)
converges weakly to a tight zero mean Gaussian variable. Similar arguments extend
to the convergence of n−1/2UT (βT ) (Ying, 1993[49]) and n
−1/2UR(βR;βT ) (Lin et al.,
2000[21]; Huang and Wang, 2003[11]) based on conditions (C1-4). So n−1/2U (β) con-
verge weakly to a multivariate normal random variable with mean zero and variance
denoted as Σ (Van Der Vaart and Wellner, 1996[39]; Lin et al., 2000[21]).
Define









j=1 E {ξTj(t;βT )}Zj
∑n
j=1 E {ξTj(t;βT )}
]
dE {NT i(t;βT )} ,
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−β′YZi} dE {NRi(t;βT )} .
Let U (β) = (U T (βT )
′,U R(βR;βT )
′,U Y (βY ;βT ,βR)
′)′ . By the conditions (C3-4),
E {ξT i(t;βT )}, E {ξRi(t;βT )}, E {NT i(t;βT )} and E {NRi(t;βT )} as functions of βT
satisfy continuity and derivative properties. According to the conditions (C1-5) and
applying the techniques of Ying (1993)[49], one can prove that there exists a matrix
An such that for every sequence dn > 0 with dn → 0 in probability, we have
sup
‖b−β‖≤dn
‖ U (b)−U (β)−Ann(b− β) ‖ /(
√
n+ n ‖ b− β ‖) = op(1).
If the eigenvalues of An are all bounded away from zero for all large enough n and
An → A where A is nonsingular, there exists a closed neighborhoodN containing β as
its interior point such that β is strongly consistent by Ying (1993)[49]. Additionally,




weakly in N .
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3.8.4 The Inference of Baseline Functions
For Model (3.1) and (3.2), with estimated regression parameters, we can estimate
A0(t) by (3.10), and estimate ΛR0(t) by a Breslow-type estimator (Breslow, 1972)





















For Model (3.1), α0(t) = E {Y0(t)|T0 ≥ t, R∗0 (dt) = 1} can be estimated by Kernel
Smoothing method (Ramlau-Hansen, 1983)
α̂0(t; β̂T ) =
∫ +∞
0
Kh(t− s)dÂ0(s; β̂T )
∫ +∞
0
Kh(t− s)dΛ̂R0(s; β̂T )
,
where Kh(x) = h





−1 xK(x)dx = 0. Using the empirical process theory (Van Der Vaart and
Wellner, 1996[39]; Kosorok, 2008[15]) and Kernel Smoothing techniques (Ramlau-
Hansen, 1983[30]) one can show that each of the processes n1/2{Â0(t; β̂T ) − A0(t)},
n1/2{Λ̂R0(t; β̂T )− ΛR0(t)} and (nh)1/2{α̂0(t; β̂T )− α0(t)} converges weakly to mean-
zero Gaussian processes by weak convergence theory for functional parameters. Since
these baseline functions are not the focus of our work, we skip details of the asymptotic
proofs.
To illustrate the performance of the estimation of α0(·) in Model (1), we conducted
the simulation studies under the Scenario 0 (see Table 3.1) where data were generated




1[T0≥t]E {Y0(t)|T0, R∗0(dt) = 1}
]








{1− Φ(2 log(t))}−1 .
Here Φ(·) is the cumulative distribution function of the standard normal distribution.
As presented in the above equation, part of the variation of α0(·) (i.e. the residual of
α0(t) − a(t)) was from the change of the survivor’s population with different times,
and this happens because of the correlation between Y0(·) and T0. Here, we used
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Table 3.5: Summary Statistics of the Simulation Studies of Estimating α0(·) in Model
(1) under Scenario 0
t = 0.5 t = 1 t = 1.5
n Bias SE Bias SE Bias SE
{βT , βR, βY } = {−0.5,−0.5,−1}
n = 100 0.013 0.201 −0.003 0.284 −0.0480 0.660
n = 200 0.004 0.144 −0.002 0.204 0.009 0.457
{βT , βR, βY } = {1, 1, 2}
n = 100 0.029 0.201 0.056 0.295 0.067 0.670
n = 200 0.014 0.147 0.019 0.194 0.035 0.435
Note: Bias, the empirical bias; SE, the empirical standard error.
the Epanechnikov Kernel (i.e. K(x) = 3/4(1 − x2)1[|x|≤1]) with the bandwidth h =
n−1/3. We summarized the simulation results in the Table 3.5 and confirmed good
performance of the estimation results.
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Chapter 4
Change Point Estimation in
Backward Process Model
4.1 INTRODUCTION
In studies of disease progression, it is often of interest to study biomarker performance
prior to the occurrence of failure events by aligning failure events as time origins and
counting time backward. For example, in studies of Alzheimer’s Disease the rate of
change in biomarker measurement before diagnosis of disease is widely recognized
as an important index for predicting the disease (Hall et al., 2000[8]; Wilson et al.,
2007[43]). However, the conventional forward perspective of stochastic processes are
not designed for the terminal behavior of processes.
Additionally, when studying trajectories of biomarkers or other longitudinal mea-
surements before the failure event such as death, researchers sometimes find the phe-
nomenon that the rate of change of biomarkers would start to shift, accelerate or
decelerate, at some special time point which is prior to the failure event by a gap
time. We name this special type of change point as backward change point to distin-
guish it from the traditional forward change point which occurs after the origin point
by a constant period of time. Backward change point is of scientific interest for biology
progression study and disease diagnosis. In particular, for Alzheimer’s disease (AD)
studies, Jack et al. (2010)[12] hypothesized that the decline of biomarkers began to
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accelerate prior to diagnosis in order such that different biomarkers characterized the
disease during different stages. Knowing the acceleration order of biomarkers decline
will help to measure disease progression precisely, and then therapeutic intervention
can be given to patients properly.
Consider the model where the failure time is T and the decline of biomarker
begins to accelerate at time point T − d for those subjects with failure time longer
than d, where d is a constant gap time. Ideally, if all of the subjects are followed
until diagnosis, the backward change point model can be analyzed by aligning the
biomarker measurements retrospectively with diagnosis as the time origin, and then
use techniques for forward change point models (e.g., Slate and Cronin, 1997[32];
Skates, Pauler, and Jacobs ,2001[31]) to estimate the parameter d.
However, in most follow-up studies, subjects may be censored due to design limi-
tations, early drop out or other reasons. For censored subjects, not only the time of
failure event is missing, the longitudinal measurements between censoring and failure
event are also unobserved. As a result, the new time origins of censored data cannot
be set and the observed longitudinal measurements cannot be indexed in backward
time index. Thus, the censoring problem of longitudinal and survival analysis studies
in backword time index is more complex than that of the studies in forward time
index. However, as a characteristic of time-to-event data, disregarding the censoring
problem will lead to biased results even if the cenoring is noninformative. To our
knowledge, there are few valid methods of modeling backward change point prob-
lems. Some researchers (Hall et al., 2000[8]; Wilson et al., 2011[44]) have already
found the scientific meaning of backward change point in applications, but did not
consider the censoring issue in their models. Additionally, longitudinal measurements
and the failure event are usually correlated and the association within data structure
should also be considered. Unfortunately, the current methods of joint modeling of
lingitudinal measuremetns and time-to-event data (Wulfsohn and Tsiatis, 1997[45];
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Henderson et al., 2000[9]; Xu and Zeger, 2001[47]; Song et al., 2002[33]; Vonesh et
al., 2006[40]; Song and Wang, 2008[34]) do not consider the backward change point
problem.
In this chapter, we develop a method to model the backward change point prob-
lem. Our method is inspired by the backward process estimation methods of Chan
and Wang (2010)[4] where stochastic counting processes are modeled by aligning fail-
ure events as time origins. The general idea of our method is that we model the
longitudinal measurement process retrospectively starting from the failure event and
the failure time will be a condition of the model just like a covariate. We present our
model in Section 4.2. The estimation method and asymptotic properties are shown
in Section 4.3. We conducted simulation studies to explore the finite sample property
of our estimation method which is presented in Section 4.4. The data analysis is pre-
sented in Section 4.5 as an illustration. Some extra discussions are shown in Section
4.6.
4.2 BACKWARD CHANGE POINT MODEL
To set notation, denote by Z a p × 1 vector of covariates, T the time to the fail-
ure event, and R(t) the number of sampling times at or before time t where t is
the forward time index. The longitudinal process Y (t) is measured at sampling
times where R(dt) = 1. Let C be the censoring time for the failure event and
longitudinal measurements. When framing the model, we only consider longitudi-
nal measurements before the failure time, i.e. 0 ≤ t ≤ T . For backward process,
denote by tB the backward time index. Define the backward process of longitudi-
nal measurements as Y B(tB;T ) = Y (T − tB) and the backward sampling process as
RB(tB;T ) = R(T )−R((T−tB)−), where 0 ≤ tB. In practice, it is possible to consider
tB > T . For example, in Alzheimer’s Disease, some individuals may experience the
shifts of biomarkers before entry into the study, but the backward change point as
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the main interest can be estimated by our model in population level if some other
individuals’ longitudinal measurements before backward change point are available.
We assume that the backward change point is localized in the study follow-up time
interval in this chapter.
Consider the following assumptions:
(A1) Y (·) is independent of C conditioning on {R(dt) = 1, T,Z}.
Assumption (A1) is proposed in forward time model, which is convenient in terms of
assumption understanding and interpretation because the data is generated in forward
time index. Assumption (A1) implies that Y B(·) is independent of C conditioning on
{
RB(dtB;T ) = 1, T,Z
}
.
In diseases progressions, biomarker variables usually change gradually along con-
tinous trajectories over time. Under Assumption (A1), we first consider the backward
change point model for this situation as
E
{
Y B(tB;T )|RB(dtB;T ) = 1, T,Z
}
= ψ0(t
B, T,Z;β) + η(tB − d)1[tB>d], (4.1)
where tB ≥ 0 and ψ0(tB, T,Z;β) is a prespecified regression function with parameter
β. The backward change point parameter is d and the corresponding shift rate
parameter is η. We assume that η 6= 0 to avoid the inidentifiability issue. It is
natural to develop the model conditioning on T , like a covariate, since the whole
backward processes are defined based on T . The condition event RB(dtB;T ) = 1
states that Model (1) models the mean trajectory and covariate effects only for the
observed Y B(·;T ). This is a natual condition for marker measurements observed
when recurent events occur. For continuous longitudinal measurements the result
generalizes to the underling Y B(·) if the longitudinal measurements and recurrent
event processes are independent with each other given Z and T . The model can be
interpreted in backward time index as that for those subjects with failure time longer
than d the slope of Y B(tB;T ) will have an additional change by η when tB > d.
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This is equivalent to that the slope of Y (t) will have an additional change by −η in
[T −d, T ] compared to that in [0, T −d) in forward time index. To simplify notations,
we define θ = (β′, η, d)′ and ψ(tB, T,Z;θ) = ψ0(t
B, T,Z;β) + η(tB − d)1[tB>d].
As an instance, we can simply define a linear regression function, termed as Model
(A),
ψA(t
B, T,Z;θ) = β0 + β1T + β2t
B + βT3Z + η(t
B − d)1[tB>d],
where β = (β0, β1, β2,β
T
3 ). In backward time index, this model has the failure event
as the time origin and the change point is located at tB = d for subjects with T > d.
The failure time T has a linear effect on the intercept value, i.e. Y B(0;T ). The slope
of Y B(tB;T ) is β2 between the failure event and the change point (i.e. 0 ≤ tB ≤ d)
and (β2 + η) after the change point (i.e. t
B > d). When in forward time index, the
change point is at (T − d) and the slope of Y (·) is −(β2 + η) for t < T − d and −β2
for t ∈ [T −d, T ]. Besides this linear regression function, other regression functions of
ψ0(t
B, T,Z;β) can be adopted as long as it has proper interpretations and satisfies
the analysis requirement. Generally, we can define a more flexible model by letting θ
be a prespecified function of {T,Z}, i.e. θ(T,Z), where different subjects are allowed
to have different slopes and change points based on their {T,Z}.
In some situations, researchers also have interest in longitudinal processes with
sudden-jump change points and this type of trajectory has a discrete change point.
Under Assumption (A1), we can also consider another model as:
E
{
Y B(tB;T )|RB(dtB;T ) = 1, T,Z
}
= ψ0(t
B, T,Z;β) + η11[tB>d] + η2(t
B − d)1[tB>d],
(4.2)
where there is an additional jump η1 at the change point and the shift rate parameter
is η2. We assume that η1 6= 0 for modeling identifiability issue. To simplify notations,
we let η = (η1, η2)
′ and let θ = (β′,η′, d)′ stand for all of the parameters in Model
(4.2). Without specification, η can also stand for η in Model (4.1). Similarly, a simple
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linear model example can be
ψA(t
B, T,Z;θ) = β0 + β1T + β2t
B + βT3Z + η11[tB>d] + η2(t
B − d)1[tB>d]
which is denoted as Model (B).
Our Models (4.1) and (4.2) allow the correlation between C and T even though
conditioning on Z. This good property will help to avoid complex debate when
considering competing risk problems where failure events caused by other reasons can
happen before our target failure event and therefore lead to censoring. For example,
subjects may die due to heart disease or cancer before having Alzheimer’s disease.
This kind of censoring time C is usually dependent of the target failure time T and
therefore the independent censoring assumption will not be accepted when competing
risk problem occurs. Because the independent censoring is not required, our Models
(4.1) and (4.2) can provide unbiased analysis even if competing risk problem exists.
4.3 ESTIMATION
4.3.1 Estimation Methods
Model (4.1) and (4.2) share the same estimating procedure which will be introduced
in this section. Define T̃ = T ∧ C and ∆ = 1[T≤C]. The observations of {R(t), Y (t)}
will stop at t = T̃ . We define the counting process of failure event by N(t) = 1[T̃≤t]∆,
and the risk set indicator function by ξ(t) = 1[T̃≥t]. Suppose the observations X i =
{T̃i,∆i, Ri(·), Yi(·), Zi}, i = 1, . . . , n, are independent and identically distributed. We
assume that d belongs to a compact set [0, τ ] and P(T̃ > d) > 0.









Y Bi (u; s)− ψ(u, s,Zi;θ)
}
RBi (du; s)Ni(ds). (4.3)





= 0 (see the Appendix). We adopt
the traditional least square method to estimate the parameters in Model (4.1 - 4.2).
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and then we find the estimator of θ such that it minimizesQn(θ), i.e. θ̂ = argminθ Qn(θ).
Denote γ = (βT ,ηT )T . One can first fix d and calculate the profile minimum point
γ̂(d) = argminγ Qn(γ, d), and then find d̂ such that d̂ = argmindQn(γ̂(d), d) and
θ̂ =
(
β̂(d̂)T , η̂(d̂)T , d̂
)T
.
As an illustration, we adopt the above method to estimate parameters in the linear
regression change point Model (A). DenoteLi(t
B, t;Zi, d) =
(




We first fix d ∈ [0, τ ] and minimizes Qn(γ, d) as a function of γ. In particular, the














B, t;Zi, d)Mi(dt, dt
B;Zi,θ). (4.5)






















































We then estimate d as
d̂ = arg min
d∈[0,τ ]
Qn(γ̂(d), d), (4.7)
by grid search. Finally, we have the least squre estimator θ̂ =
(
















and Q(θ) = E {q(θ;X)}, where E {·} means the expectation under true parameters
θ0. We define ρ1(θ,θ0) =‖ θ − θ0 ‖ where ‖ · ‖ stands for the L2 norm. The
consistency property and the weak convergence property of θ̂ will be established
under the Assumption (A1) and the following conditions:
(i) θ0 lies in a compact set Θ in the Euclidean space.
(ii) {Z, T, R(·), Y } is bounded and {Z, T} has a positive and continuous density
function.
(iii) ψ0(t
B, T,Z;β), is uniformly bounded, has continuous second order differential
function with respect to β, belongs to Donsker class, and ψ(tB, T,Z;θ) is iden-
tifiable.

















, (tB − d),−η
)T



















n|(Qn −Q)(θ)− (Qn −Q)(θ0)| ≤ Kδ,
where K is a finite positive constant.
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The conditions (i-ii) are commonly-used regular conditions for random variables
of stochastic processes. The conditions (iii-vi) primary mean that the model function
ψ0(·) should be relatively smooth, the derived derivative function matrix is non-
sigular, and the corresponding Qn(·) is easy to handle. We present the consistency
of θ̂ in Theorem (4.3.1). Theorem (4.3.2) states that the rates of convegence of θ̂ is
√
n, and Theorem (4.3.3) proves that θ̂ has normal limiting distributions.
Theorem 4.3.1 Under conditions (i-iii), there exists a neighborhood Θ of θ0 such
that θ̂ lies in Θ, and then it converges in probability to θ0 as n→ ∞.
Theorem 4.3.2 Under conditions (i-vi),
√
nρ1(θ̂,θ0) = OP (1).






converges weakly to a mean
zero multivariate Gaussian variable.
Secondly, we introduce the inference properties of Model (4.2). We define ρ2(θ,θ0) =
√
‖ β − β0 ‖22 + ‖ η̂ − η0 ‖22 +|d̂− d0|. Beside conditions (i-iii), we also need the fol-
lowing conditions:






T , 1, (t
B − d),−η2
)T
. There exists a neigh-



















n|(Qn −Q)(θ)− (Qn −Q)(θ0)| ≤ Kδ,
where K is a finite positive constant.
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(vii∗) I1(θ) = E[−∂
2q(θ;X)
∂γ∂γ ′ ] and I2(θ) = Var[
∂q(θ;X)
∂γ ] exist, and I1(θ0) is non-
singular.
We present the consistency of θ̂ in Theorem (4.3.4). Theorem (4.3.5) states that
the rates of convegence of d̂ and γ̂ are n and
√
n separately. Since the convergence
rate of d̂ is faster than that of γ̂, the asymptotic distribution of γ̂ is still the norm
distribution which is shown in Theorm (4.3.6).
Theorem 4.3.4 Under conditions (i-iii), there exists a neighborhood Θ of θ0 such
that θ̂ lies in Θ, and then it converges in probability to θ0 as n→ ∞.
Theorem 4.3.5 Under conditions (i-iii, iv∗-vii∗),
√
nρ2(θ̂,θ0) = OP (1).
Theorem 4.3.6 Under conditions (i-iii, iv∗ - vii∗),
√






Achieving the weak convergence property for d̂ in Model (4.2) is challenging.
The reason is that traditional weak convergence results of M-estimator are based
on Taylor expansions of the induced estimating equations (e.g. the score function
in the maximum likelihood estimation method) in a small neighborhood of the true
value. While, the function Qn(θ) in our method is not differentiable over the change
point parameter d and therefore the traditional technique can not be used. Some
researchers (Pons, 2003[29]; Kosorok and Song, 2007[16]) found that the asymptotic
normality does not hold for the change point parameter in their problem settings.
4.4 Simulation Studies
We conducted abundant simulation studies to evaluate the performance of the pro-
posed estimating method for both Model (4.1) and (4.2). The Model (4.1) and (4.2)
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shared the same data generation procedures. Let τ be the maximum follow-up time.
The ith (i = 1, . . . , n) individual’s data were generated by the following steps:
• Generate the covariate vector Zi. Here, we only considered two covariates which
had Bernoulli and standard normal distributions separately.
• Generate the potential failure time Ti and censoring time Ci given Zi. Since
Ti and Ci were potentially correlated with each other, we generated a random
vector ωi = (ωi1, ωi2)
T from a multivariate normal distribution where the mean
and covariance matrix were functions of Zi, denoted as µT (Zi) and ΣT (Zi)
separately. Define Ti = exp(ωi1) and Ci = exp(ωi2).
• Generate the sampling time process Ri(·) on [0, τ ] from stationary Poisson pro-
cess which was independent with {Zi, Ti, Ci}.
• Given Ti and Zi, generate the longitudinal variable at each sampling time in
backward direction. Here, we only considered linear regression models, i.e.
Model (A) and (B) for continuous and discrete types of backward change point
models separately. The error term εi(t) had normal distributionN(0, σ
2(Zi, Ti)),
where σ2(·, ·) was a prespecified function.
The simulation procedure follows the Model (4.1) and (4.2) exactly and was deter-
mined by prespecified components: sample size n, τ , functions {µT (·),ΣT (·), σ2(·, ·)},
and parameters (d,β′, η)′. We simulated multiple type of data sets by using different
prespecified components where 1, 000 simulated data sets were repeatedly generated
for each case.
The simulation results were summarized in Table 4.1-4.2 for Model (4.1)and Table
4.3-4.4 for Model (4.2). In Scenario 1, the variance of the error term εi(t) depended on
both of the failure time T and covariates Z, and the failure time were correlated with
censoring time C. While in Scenario 2, Y (·) was independent with T conditioning on
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Table 4.1: Summary Statistics of the Simulation Studies of Scenario 1 for Model (4.1)
n βT η d
Scenario 1: µ(Z) = (Z1 + Z2, Z1 + Z2 + 2)
′, σ2(Z, T ) = min( 1
5
T exp(Z1 + Z2), 1)
Σ1,1 = max((|Z1 + Z2|+ 1)/2, 1), Σ2,2 = max(exp(Z1 + Z2)/3, 1),
Σ1,2 = Σ2,1 =
√
|Σ(Z)[1, 1]Σ(Z)[2, 2]− 0.5|, τ = 15.






(0.0867, 0.0185, 0.0529, 0.0994, 0.0599)












(0.0380, 0.0079, 0.0228, 0.0419, 0.0254)













(0.1071, 0.0186, 0.1177, 0.0999, 0.0603)












(0.0437, 0.0079, 0.0478, 0.0420, 0.0255)







Note: B, the empirical bias; V , the empirical standard error; CR, the coverage rate of 95% confidence
interval.
Z, and T and C are uncorrelated. We used the empirical bias, standard errors, and
95% confidence interval coverage rate to evaluate the performance of the estimation
method. The 95% confidence intercal of d̂ in Model (4.2) was calculated by using
the simple Bootstrap method. As shown in Table 4.1-4.4, the estimating method
performed well in all of the situations considered here. In particular, to compare
the convergence rates of d̂ in Model (4.1) and (4.2), we calculated the variance of
√
n(d̂ − d0) in Model (4.1) and n(d̂ − d0) in Model (4.2) and ploted the density
functions of d̂ − d0 with multiple sample sizes (see Table 4.5 and Figure 4.1). The
results were consistent with our statements.
4.5 Data Analysis
In this section we consider the application of our models on the data from the
Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) cohort
study which aims to identify biomarkers associated with the development of Alzheimer’s
Disease (AD). The study was conducted by NIH from 1995 to 2005, and was re-
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Table 4.2: Summary Statistics of the Simulation Studies of Scenario 2 for Model (4.1)
n βT η d
Scenario 2: µ(Z) = (Z1 − Z2 + 1, Z1Z2 + 4)′, σ2(Z, T ) = 110 (|Z1Z2|+ 1)
Σ1,1 = (|Z1 − Z2|+ 1)/2, Σ2,2 = (|Z1 + Z2|+ 1)/2,
Σ1,2 = Σ2,1 = 0, τ = 10.





(0.0004,−0.0001, 0.0002, 0.0000, 0.0006)
(0.0379, 0.0081, 0.0156, 0.0306, 0.0227)












(0.0161, 0.0033, 0.0068, 0.0130, 0.0093)












(0.0005,−0.0002, 0.0003, 0.0002, 0.0005)
(0.0473, 0.0081, 0.0363, 0.0306, 0.0228)












(0.0197, 0.0033, 0.0158, 0.0130, 0.0093)







Note: B, the empirical bias; V , the empirical standard error; CR, the coverage rate of 95% confidence
interval.
Table 4.3: Summary Statistics of the Simulation Studies of Scenario 1 for Model (4.2)
n βT ηT d
Scenario 1: µ(Z) = (Z1 + Z2, Z1 + Z2 + 2)
′, σ2(Z, T ) = min( 1
5
T exp(Z1 + Z2), 1)
Σ1,1 = max((|Z1 + Z2|+ 1)/2, 1), Σ2,2 = max(exp(Z1 + Z2)/3, 1),
Σ1,2 = Σ2,1 =
√
|Σ(Z)[1, 1]Σ(Z)[2, 2]− 0.5|, τ = 15.






(0.0864, 0.0186, 0.0527, 0.0993, 0.0599)












(0.0382, 0.0079, 0.0228, 0.0419, 0.0255)













(0.1058, 0.0186, 0.1176, 0.1002, 0.0606)












(0.0429, 0.0079, 0.0463, 0.0421, 0.0255)







Note: B, the empirical bias; V , the empirical standard error; CR, the coverage rate of 95% confidence
interval.
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Table 4.4: Summary Statistics of the Simulation Studies of Scenario 2 for Model (4.2)
n βT ηT d
Scenario 2: µ(Z) = (Z1 − Z2 + 1, Z1Z2 + 4)′, σ2(Z, T ) = 110 (|Z1Z2|+ 1)
Σ1,1 = (|Z1 − Z2|+ 1)/2, Σ2,2 = (|Z1 + Z2|+ 1)/2,
Σ1,2 = Σ2,1 = 0, τ = 10.






(0.0380, 0.0801, 0.0154, 0.0306, 0.0227)












(0.0161, 0.0033, 0.0066, 0.0130, 0.0093)













(0.0471, 0.0081, 0.0360, 0.0306, 0.0229)












(0.0196, 0.0033, 0.0156, 0.0130, 0.0093)







Note: B, the empirical bias; V , the empirical standard error; CR, the coverage rate of 95% confidence
interval.
Table 4.5: Compare the Convergence Rates of d̂ in Model (4.1) and (4.2)
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Figure 4.1: Compare the Convergence Rates of d̂ in Model (4.1) and (4.2).
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Table 4.6: Descriptive Statistics of BIOCARD Data Analysis
#Subjects #Censored/ #ApoE4+/ #Male/ Mean Years of Mean Baseline
#Uncensored #ApoE4- #Female Education (SD) Age (SD)
289 226/63 91/198 118/171 17.078 (2.371) 56.940 (9.960)
administrated by a research team at Johns Hopkins School of Medicine after since
2009. Subjects enrolled in the study were cognitively normal at entry time and data
including cognitinve scores were longitudinally collected during the study.
Our main object is to estimate the backward change point of the cognitive score
WAIS-RDigitSymbol before the onset of clinical symptoms of AD by using our model
(A). In this analysis, we adjusted the covariate effects of years of education, baseline
age, gender, and the ε4 allele of the apolipoprotein E (ApoE) gene type (encoded as
1 for carriers and 0 for non-carriers) which is the main genetic risk factor associated
with AD dementia (Farrer et al., 1997[5]). Totally, we had 289 subjects, consisting
of 63 uncensored subjects and 226 censored subjects. More descriptive statistics are
presented in Table 4.6.
The analysis results are reported in Table 4.7. In backward time index and with
the failure event as the time origin, the change point is located at d̂ = 5.857. Because
the uncensored sample size was small and the measurement of each subject were not
dense, the 95% confidence interval of d̂ was relative wide comparing to the study
follow-up time (20 years). The failure time T together with other covariates has a
linear effect on the intercept, i.e. the WAIS-RDigitSymbol score at the failure time.
With tB increasing by one unit, Y B(tB;T ) increased by 0.082 significantly between
the failure event and change point (0 ≤ tB ≤ 5.857) and increased by 0.005 after the
change point (tB > 5.857). However the change shift was not significant according to
the 95% confidence interval of η̂, which is consistent with the wide confidence interval
of d̂. As the model interpretation in the forward time index, the change point is at
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Table 4.7: Summary of BIOCARD Data Analysis
Estimator Standard Error 95% Confidence Interval
Intercept -0.545 0.561 (-1.649, 0.559)
T -0.012 0.0182 (-0.048, 0.023)
tB 0.082 0.037 (0.009, 0.155)
Gender (Male) -0.180 0.142 (-0.458, 0.099)
Baseline age -0.023 0.009 (-0.041, -0.006)
Education 0.070 0.031 (0.008, 0.132)
ApoE4 0.013 0.150 (-0.282, 0.307)
η̂ -0.077 0.053 (-0.182, 0.028)
d̂ 5.857 2.228 (1.470, 10.244)
T −5.857, and the WAIS-RDigitSymbol score decreased by −0.005 before the change
point and −0.082 after the change point. The results were mainly consistent with the
biological interpretation.
4.6 Discussion
In this chapter, we have proposed a statistical method to study the terminal behavior
of stochastic processes and estiamte the backward change point prior to the failure
event. Our approach considers the censoring problem which is, to our knowledge,
usually ignored when estimating the backward change point. Especially, our method
allows the censoring time to be associated with the failure time and therefore can
be applied with the occurence of competing risks issue. With the spirit of semipara-
metric models, our method has few restrictions on the variable distributions or the
correlations within the data structure except for a few common assumptions. We also
studied the asymptotic properties of our method and confirmed them by simulation
studies. We have illustrated our method by applying it to the BIOCARD data.
Unfortunately, our methods take few advantage of the available data of the cen-
sored subjects. In many follow up studies, the censoring rate can be very high (e.g.
the censoring rate is about 0.8 in Biocard cohort study) and how to use the data from
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the censored subjects can be an interesting research topic in the future. Moreover,
there have been many studies in developing forward-in-time models for stochastic pro-
cesses and some researchers have started to consider models in backward time scale,
but few efforts have been conducted to combine models in forward and backward
together. We think that modeling in both forward and backward time index may be
a solution to how to use the data of censored subjects and should be considered as
the future work.
4.7 Proofs
4.7.1 Proof Estimation Method
Suppose Model (4.1) is true and θ0 is the true parameter. If t
B ≤ t, by the property











B; t)− ψ(tB, t,Zi;θ0)
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RBi (dt






If the subject is censored (i.e. Ni(dt) = 0), the backward processes can not be
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B; t)− ψ(tB, t,Zi;θ0)
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B; t) | Ni(dt) = 1,Zi
}
E {Ni(dt) | Zi} .
(4.9)
Similarly, by applying the property of conditional expectation with conditioning
on RBi (dt
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B; t) | Ni(dt) = 1,Zi
}
E {Ni(dt) | Zi}
=0.
(4.12)





= 0, and therefore
the equation exists as well.
4.7.2 Proof of Theorem (4.3.1) (4.3.4)
Theorem (4.3.1) (4.3.4) share the same proof. By the property of conditional expec-










Y B(tB; t)− ψ(tB, t,Z;θ)













































where the equation holds if and only if θ = θ0 based on the identifiable property
in condition (iii). Based on conditions (i-iii), ψ(tB, t,Z;θ) belongs to Donsker class,
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Lipschitz continuous functions of Donsker classes are Donsker, and furthermore if a
function is Donsker, it is also Glivenko-Cantelli, we know that supθ∈Θ |Qn(θ)−Q(θ)|
converges in probability to zero as n → 0. Since Q(θ) is continuous, we have θ̂
converges to θ0 in probability as n→ 0 according to the Argmax Theorem (Kosorok,
Theorem 14.1, 2008[17]).
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+ o(‖ θ − θ0 ‖22).
Based on the conditions (iv-v), there exists a positive constants c1 such that
Q(θ)−Q(θ0) ≥ c1 ‖ θ − θ0 ‖22 (4.15)
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in a small neighbourhood of θ0. Because of the condition (vi), the desired conver-
gence rate follows (Kosorok, Theorem 14.4, 2008[17]). Note of, the proofs in Kosorok
(2008)[17] was originally for suddern-jump change point models, but we have shown
that the techniques can be applied to continuous change point models like Model
(4.1)
4.7.4 Proof of Theorem (4.3.3)
Denote T B1 = {tB : tB ≤ d∧ d0}, T B2 = {tB : d < tB ≤ d0}, T B3 = {tB : do < tB ≤ d},
and T B4 = {tB : tB > d ∨ d0}. We consider Qn(θ) on the four spaces separately and
denote Gn(θ,θ0; T Bk ) = {Qn(θ)−Qn(θ0)}1[tB∈T Bk ] (k = 1, 2, 3, 4). It can be easily
shown that


























































ψ(tB, t,Zi;θ)− ψ(tB, t,Zi;θ0)
}2
+ 2ψ(tB, t,Zi;θ)ψ(t
B, t,Zi;θ0)− 2Y Bi (tB; t)ψ(tB, t,Zi;θ)























B; t)− ψ(tB, t,Zi;θ0)
) (






We firstly consider Gn(θ,θ0; T B2 ) and divide it into two parts, i.e. Gn(θ,θ0; T B2 )(1)
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and Gn(θ,θ0; T B2 )(2), with






























B; t)− ψ(tB, t,Zi;θ0)
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We will show that Gn(θ,θ0; T B2 )(1) = op(‖ θ − θ0 ‖2) and Gn(θ,θ0; T B2 )(2) = op(‖


















By applying Taylor Expansion on ψ0(t





























































































n ‖ θ − θ0 ‖2
.
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≤c3 | d− d0 |
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we denote the envelope of f1(θ;X i), on the right side of the inequality, as F1i, and
it can be easily proved that E{F 21i} = O(1/n2). Since {Z, T} has a positive and con-
tinuous density function (Condition (ii)), by Lemma 2.1 in Kim and Kim (2008)[13],



















































f1(θ;X i)−Ef1(θ;X i) |= Op(‖ θ−θ0 ‖)+Op(1/
√
n),
and Gn(θ,θ0; T B2 )(1) =‖ θ − θ0 ‖2 {
∑n













B; t)− ψ(tB, t,Zi;θ0)
)
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and it is easily to prove that E{f2(θ;X i)} = 0. Since Y Bi (tB; t) and ψ(tB, t,Zi;θ0)
are bounded, there exists a positive constant c5 such that
sup
{θ:‖θ−θ0‖<δ}










We define the envelope of f2(θ;X i), on the right side of the inequality, as F2i, and
it can be easily proved that E{F 22i} = O(| d − d0 | /n). Again, by the Lemma 2.1 in



















































f2(θ;X i)− Ef2(θ;X i) |= O(
‖ θ − θ0 ‖√
n
),
and Gn(θ,θ0; T B2 )(2) =‖ θ − θ0 ‖ {
∑n
i=1 f2(θ;X i)} = op(‖ θ − θ0 ‖ /
√
n).
Hence, we have that G(θ,θ0; T B2 ) = op(‖ θ− θ0 ‖2) + op(‖ θ− θ0 ‖ /
√
n), and we





By applying Taylor Expansion to G(θ,θ0; T B1 ) and G(θ,θ0; T B4 ), we have
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B; t)− ψ(tB, t,Zi;θ0)
)
op(‖ θ − θ0 ‖)
]
RBi (dt
B; t)Ni(dt) + op(‖ θ − θ0 ‖2).
Hence,
Gn(θ,θ0)












































































































and by the Central Limit Theorem V n converge weakly to a mean zero multivariate























= (θ − θ0)T W (θ − θ0)−
2 (θ − θ0)T√
n


























+ op(‖ θ − θ0 ‖2) + op(‖ θ − θ0 ‖ /
√
n).
Consider the convergence rate in the Theory (4.3.2) and the fact that θ̂ reaches the
minimum point of Qn(θ), we have






















= W−1V n + op(1) → W−1V ∼
N (0,W−1ΣW−1). So the desired result is proved.
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B, t,Z;β) + η1 + η2(t












B, t,Z;β) + η1 + η2(t









We denote the four terms in the above equation as B1 − 4. By using the similar
arguments in the proof of Theorem (4.3.2), on can prove that based on the conditions
(iv∗ -vii∗) there exist positive constants c7 such that in a small neighbourhood of θ0
B1 +B4 ≥ c7
(
‖ β − β0 ‖22 + ‖ θ − θ0 ‖22
)
(4.18)
Because η10 6= 0, one can easily prove that there exist positive constants c8 such that
in a small neighbourhood of θ0 B2 + B3 ≥ c8|d− d0|. Therefore, one can prove that
there exist positive constants c9 such that in a small neighbourhood of θ0
Q(θ)−Q(θ0) ≥ c9ρ2(θ,θ0)2. (4.19)
Applying the condition (v) again, we have the desired convergence rate(Kosorok,
Theorem 14.4, 2008).
4.7.6 Proof of Theorem (4.3.6)
Since conditions (i-iii) guarantee that θ̂ is consistent and θ0 is assumed to line in
the interior of Θ, we know that θ̂ lies in a small neighborhood of θ0 and cannot be
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the boundary with sufficiently large probability. This implies that the maximum is











(γ̂ − γ0), (4.20)
where ‖ γ∗ − γ0 ‖2≤‖ γ̂ − γ0 ‖2. We define Jn(d,γ) = −∂2Qn(d,γ)/∂γ∂γT . By the


















The second equation is because J−1n (d,γ) and ∂Qn(d̂,γ)/∂γ∂γ
T are uniformly con-
tinuous with respect to d. Theorem (4.3.5) implies that
√
nO(|d0−d̂|) = o(1). Since γ̂
is consistent and by condition (vi), J−1n (d0,γ
∗) converges to I1(θ0)
−1 in a small neigh-
borhood of θ0. By Central Limit Theorem,
√
n∂Qn(d0,γ0)/∂γ∂γ
T → N(0, I2(θ0))
weakly. By Slutsky’s Theorem, we have
√





weakly in a small neighborhood of θ0.
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Chapter 5
Disccusion and Future Research
In this dissertation, we have focused on the approaches for joint modeling of longi-
tudinal measurements, recurrent events, and failure time data which are frequently
observed in medical studies. As introduced in Chapter 1, there are two types of
longitudinal measurements: (i) repeated measurements collected at sampling times,
and (ii) marker measurements observed when recurrent events occur. In practice, the
longitudinal measurments, recurrent events, and failure time data are usually corre-
lated with each other for both types of data. Ignoring the correlation within the data
structure will lead to non-negligible biases and therefore the traditional methods for
longitudinal data analysis (Liang and Zeger, 1986[19]; Laird and Ware, 1982[18]) can
not be applied in the situation where sampling times and failure times are dependent
with the longitudinal measurements.
We have developed a new joint modeling method for longitudinal measurements,
recurrent events, and failure events data where all of the three components of data
are treated as outcomes. Without requiring restrict assumptions on recurrent event
processes, the proposed model is applicable to both types of longitudinal measure-
ments, (i) and (ii). On the basis of the survivors’ population, the model avoids the
disputing assumption on the existence of recurrent events or longitudinal measure-
ments after the failure event. As the model does not involve latent variables, com-
putationally it is simpler and easier to adopt when comparing to the shared frailty
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model. The proposed model and estimation inference can be generalized to analyze
left-truncated and right-censored data. The proposed model involves semiparamet-
ric structure in each of the three sub-models, for failure time, recurrent events and
longitudinal measurements, and the baseline functions in the model are unspecified.
Our model also possesses a specific feature that the forward time model is equivalent
to the backward-in-time model for recurrent events and longitudinal measurements,
where the two models share the same regression parameter values.
In addition, it is also of interest to study the terminal behavior of biomarkers
prior to the occurrence of failure events by aligning failure events as time origins and
counting time backward. This research topic is primarily motivated by the Biomarkers
of Cognitive Decline Among Normal Individuals (BIOCARD) cohort study which
aims at identifying biomarkers associated with the development of Alzheimer’s Disease
(AD) procession. In studies of Alzheimer’s Disease the rate of change in biomarker
measurement before diagnosis of disease is widely recognized as an important index
for predicting the disease (Hall et al., 2000[8]; Wilson et al., 2007[43]). Moreover,
when studying trajectories of biomarkers or other longitudinal measurements before
the failure event, researchers sometimes find the phenomenon that the rate of change
of biomarkers would start to shift, accelerate or decelerate, at some special time
point prior to the failure event by a gap time which is named as the backward change
point. However, the conventional forward perspective of stochastic processes are not
designed for the terminal behavior of processes. It is even more challenging to estimate
the backward change point because of the censoring problem and the complex data
structure.
In this dissertation, we have proposed a statistical method to study the terminal
behavior of stochastic processes and estiamte the backward change point prior to the
failure event. Our approach cleverly solves the censoring problem which is, to our
knowledge, usually ignored when estimating the backward change point. Especially,
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our method allows the censoring time to be associated with the failure time and there-
fore can be applied with the occurence of competing risks issue. With the spirit of
semiparametric models, our method has few restrictions on the variable distributions
or the correlations within the data structure except for a few common assumptions.
We also studied the asymptotic properties of our method and confirmed them by sim-
ulation studies. It is noticed that we have only provied the asymptotic distribution for
the continuous backward change point estimator in this dissertation and developing
the asymptotic distribuition of the sudden-jump backward change point estimator is
more difficult and needs further study. We have illustrated our method by applying
it to the BIOCARD data and the applications on other data sets can be done in the
future.
There are still many open research topics not addressed in this dissertation. First,
the joint modeling method in Chapter 3 only has only considered the longitudinal
measurements, recurrent events, and failure time data under the assumption of inde-
pendent censoring, and therefore can not be applied in the situation where competing
risk occurs. Competing risk is an event that either avoids the observation of the fail-
ure event of interest or changes the opportunity of the occurence of the failure event.
Competing risk is commonly observed in survival analysis. For example, in studies
of Alzheimer’s Disease, subjects can die due to cancer or other diseases before the
onset of clinical symptoms of Alzheimer’s Disease and the death will terminate the
observation of the development of Alzheimer’s Disease and corresponding longitudi-
nal measurements. The competing risk is usually correlated with the failure event of
interest and therefore models which are developed based on the assumption of inde-
pendent censoring can not be applied to analyze data with competing risks. Joint
modeling of longitudinal measurements, recurrent events, and failure time data with
competing riks is of practical meaning but very challenging, and therefore more efforts
can be made in this direction for future study.
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Second, the backward change point models in Chapter 4 take few advantage of
the available data of the censored subjects. How to use the data from the censored
subjects can be an interesting research topic in the future because the censoring rate
can be very high in many follow up studies (e.g. the censoring rate is about 0.8
in Biocard cohort study). Moreover, there have been many studies in developing
forward-in-time models for stochastic processes and some researchers have started
to consider models in backward time scale, but few efforts have been conducted to
combine models in forward and backward together. We think that modeling in both
forward and backward time index may be a solution to using the data of censored
subjects and should be considered as the future work.
In conclusion, the proposed joint models for longitudinal measurements, recurrent
events, and failuretime data and the backward change point models in this dissertation
may initiate a wave of future research on both statistical applications and methods.
The proposed models can help to answer a wide range of public health or medical
scientific questions and understand the nature history of biology processes.
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